Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT

Spyridonidis, Alexandros and Labopin, Myriam and Savani, Bipin and Giebel, Sebastian and Bug, Gesine and Schoenland, Stefan and Kroeger, Nicolaus and Stelljes, Matthias and Schroeder, Thomas and McDonald, Andrew and Blau, Igor-Wolfgang and Bornhaeuser, Martin and Rovira, Montse and Bethge, Wolfgang and Neubauer, Andreas and Ganser, Arnold and Bourhis, Jean Henri and Edinger, Matthias and Lioure, Bruno and Wulf, Gerald and Schaefer-Eckart, Kerstin and Arat, Mutlu and Peric, Zinaida and Schmid, Christoph and Bazarbachi, Ali and Ciceri, Fabio and Nagler, Arnon and Mohty, Mohamad (2023) Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT. HEMASPHERE, 7 (1): e812. ISSN , 2572-9241

Full text not available from this repository. (Request a copy)

Abstract

In this registry-based study, we compared outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in adult patients with acute lymphoblastic leukemia (ALL) transplanted in first complete remission (CR-1), following conditioning with total body irradiation (TBI) at a standard 12-Gray or at a lower 8-Gray total dose. Patients received fludarabine (flu) as the sole chemotherapy complementing TBI. Eight-Gray TBI/flu was used in 494 patients and 12-Gray TBI/flu in 145 patients. Eighty-eight (23.1%) and 36 (29%) of the patients had Ph-negative B-ALL, 222 (58.3%) and 53 (42.7%) had Ph-positive B-ALL, 71 (18.6%) and 35 (28.2%) T-ALL, respectively (P = 0.008). Patients treated with 8-Gray were older than ones received 12-Gray (median 55.7 versus 40.3 years, P < 0.0001) and were more frequently administered in vivo T-cell depletion (71% versus 40%, P <0.0001). In a multivariate model adjusted for age, type of ALL, and other prognostic factors, leukemia-free survival (primary endpoint) as well as relapse, nonrelapse mortality, overall survival, and GVHD-free, relapse-free survival were not influenced by the TBI dose. These results were confirmed when we focused on patients <55 years of age (median 47 years). Patients with Ph-positive ALL or T-ALL had significantly better survival outcomes than ones with Ph-negative B-ALL, mainly due to significantly fewer relapses. We conclude that 8-Gray TBI is sufficient for adult patients with ALL transplanted in CR-1 with no additional benefit of augmenting the conditioning intensity to 12-Gray.

Item Type: Article
Uncontrolled Keywords: HEMATOPOIETIC-CELL TRANSPLANTATION; INTENSITY; REGIMENS; BLOOD;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 19 Apr 2024 13:11
Last Modified: 19 Apr 2024 13:11
URI: https://pred.uni-regensburg.de/id/eprint/60887

Actions (login required)

View Item View Item